
- Oncology NEWS International Vol 17 No 7
- Volume 17
- Issue 7
Symptom Screen Plus CA125 Detects Early Ovarian Ca
Women’s reports of persistent, recent-onset symptoms linked to ovarian cancer-abdominal or pelvic pain, difficulty eating or feeling full quickly, and abdominal bloating-combined with CA125 testing may improve the early detection of ovarian cancer by 20%, according to Fred Hutchinson Cancer Research Center investigators (Cancer, published online June 23, 2008).
Women’s reports of persistent, recent-onset symptoms linked to ovarian cancer-abdominal or pelvic pain, difficulty eating or feeling full quickly, and abdominal bloating-combined with CA125 testing may improve the early detection of ovarian cancer by 20%, according to Fred Hutchinson Cancer Research Center investigators (Cancer, published online June 23, 2008).
The researchers gave a four-question symptom-screening questionnaire to 75 women about to undergo surgery for a pelvic mass who were later diagnosed with ovarian cancer (cases) and 254 healthy women at high risk for ovarian cancer (controls). The questionnaire and CA125 test used alone each detected about 50% of early-stage cases. Used together, the tests found 80.6% of early-stage cases, said M. Robyn Andersen, PhD, of the Public Health Sciences Division.
Articles in this issue
about 17 years ago
National Cancer Survivors Dayover 17 years ago
New Indication for Velcade in Previously Untreated Myelomaover 17 years ago
Risk Factors for Mantle Cell Lymphoma Identifiedover 17 years ago
RAS Mutations Enhance Chemotherapy in AMLover 17 years ago
Antidiabetic Agent Metformin May Boost pCRs in Breast Caover 17 years ago
Eisai Seeks Full FDA Approval for Ontak for CTCLover 17 years ago
Cisplatin Linked to Cardiac Complications in Testicular Ca Patientsover 17 years ago
Updated X-ACT Study Results Presentedover 17 years ago
ThromboGenics and BioInvent Announce Alliance with Rocheover 17 years ago
Gene Signature Identifies Low-Risk Patients in MAGE-A3 TrialNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.